These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11034075)

  • 1. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer.
    Suzuki S; Moore DH; Ginzinger DG; Godfrey TE; Barclay J; Powell B; Pinkel D; Zaloudek C; Lu K; Mills G; Berchuck A; Gray JW
    Cancer Res; 2000 Oct; 60(19):5382-5. PubMed ID: 11034075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas.
    Sonoda G; Palazzo J; du Manoir S; Godwin AK; Feder M; Yakushiji M; Testa JR
    Genes Chromosomes Cancer; 1997 Dec; 20(4):320-8. PubMed ID: 9408747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of benign, low-grade, and high-grade ovarian tumors.
    Iwabuchi H; Sakamoto M; Sakunaga H; Ma YY; Carcangiu ML; Pinkel D; Yang-Feng TL; Gray JW
    Cancer Res; 1995 Dec; 55(24):6172-80. PubMed ID: 8521410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis.
    Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D
    Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of early- versus late-stage ovarian tumors.
    Shridhar V; Lee J; Pandita A; Iturria S; Avula R; Staub J; Morrissey M; Calhoun E; Sen A; Kalli K; Keeney G; Roche P; Cliby W; Lu K; Schmandt R; Mills GB; Bast RC; James CD; Couch FJ; Hartmann LC; Lillie J; Smith DI
    Cancer Res; 2001 Aug; 61(15):5895-904. PubMed ID: 11479231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer stage and outcome by array-based comparative genomic hybridization.
    Blaveri E; Brewer JL; Roydasgupta R; Fridlyand J; DeVries S; Koppie T; Pejavar S; Mehta K; Carroll P; Simko JP; Waldman FM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7012-22. PubMed ID: 16203795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation.
    Kiechle M; Jacobsen A; Schwarz-Boeger U; Hedderich J; Pfisterer J; Arnold N
    Cancer; 2001 Feb; 91(3):534-40. PubMed ID: 11169935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage.
    Partheen K; Levan K; Osterberg L; Helou K; Horvath G
    Genes Chromosomes Cancer; 2004 Aug; 40(4):342-8. PubMed ID: 15188458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
    Rozeman LB; Szuhai K; Schrage YM; Rosenberg C; Tanke HJ; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    Cancer; 2006 Jul; 107(2):380-8. PubMed ID: 16779802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma.
    Staebler A; Karberg B; Behm J; Kuhlmann P; Neubert U; Schmidt H; Korsching E; Bürger H; Lelle R; Kiesel L; Böcker W; Shih IeM; Buchweitz O
    Genes Chromosomes Cancer; 2006 Oct; 45(10):905-17. PubMed ID: 16845658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal aberrations detected by comparative genomic hybridization predict outcome in patients with colorectal carcinoma.
    Liu XP; Kawauchi S; Oga A; Sato T; Ikemoto K; Ikeda E; Sasaki K
    Oncol Rep; 2007 Jan; 17(1):261-7. PubMed ID: 17143507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
    Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
    Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease.
    Kim SW; Kim JW; Kim YT; Kim JH; Kim S; Yoon BS; Nam EJ; Kim HY
    Genes Chromosomes Cancer; 2007 Jan; 46(1):1-9. PubMed ID: 17044060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele loss on chromosome 1p36 in epithelial ovarian cancers.
    Alvarez AA; Lambers AR; Lancaster JM; Maxwell GL; Ali S; Gumbs C; Berchuck A; Futreal PA
    Gynecol Oncol; 2001 Jul; 82(1):94-8. PubMed ID: 11426968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CyclinD1 copy number changes with histological type in ovarian tumors.
    Dimova I; Zaharieva B; Raicheva S; Milev I; Dimitrov R; Doganov N; Aleksandrov M; Todorov T; Toncheva D
    Acta Oncol; 2004; 43(7):675-9. PubMed ID: 15545188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations related to lymph node metastasis and peritoneal dissemination in epithelial ovarian cancers.
    Umayahara K; Numa F; Inokuma A; Sueoka K; Kawasaki K; Hirakawa H; Emoto T; Sakaguchi Y; Nawata S; Ogata H; Sakamoto M; Hasumi K; Kawauchi S; Sasaki K; Kato H
    Oncol Rep; 2002; 9(5):1115-9. PubMed ID: 12168082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.